| Mrs Fatima I Ayuba-udoiwod, CRNA | |
|
1 Kish Hospital Dr, Dekalb, IL 60115-9602 | |
| (630) 936-4029 | |
| (630) 936-4032 |
| Full Name | Mrs Fatima I Ayuba-udoiwod |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 1 Kish Hospital Dr, Dekalb, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598067514 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 209008519 (Illinois) | Primary |
| 163W00000X | Registered Nurse | 041342973 (Illinois) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cgh Medical Center | Sterling, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cgh Medical Center | 6103723267 | 156 |
| Ias Illinois Pc | 9638530991 | 24 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | Windy City Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932248622 PECOS PAC ID: 9234033572 Enrollment ID: O20031120000022 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | Kane Anesthesia Associates Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568407401 PECOS PAC ID: 2769388438 Enrollment ID: O20031211000990 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | Gottlieb Midwest Anesthesiologists, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003832767 PECOS PAC ID: 8123929940 Enrollment ID: O20040115000619 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | Midwest Anesthesia Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255380184 PECOS PAC ID: 6204737596 Enrollment ID: O20040120000034 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | Anesthesia Associates, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952308223 PECOS PAC ID: 2961303425 Enrollment ID: O20040224000185 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | Valley Pain Care Centers, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194722058 PECOS PAC ID: 7517858632 Enrollment ID: O20040320000066 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | Cgh Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902854623 PECOS PAC ID: 6103723267 Enrollment ID: O20040928000513 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | Quantum Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033546833 PECOS PAC ID: 7618100751 Enrollment ID: O20140425001247 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | Midwest Anesthesia Providers Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295189082 PECOS PAC ID: 9830480581 Enrollment ID: O20160628000182 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | Clinical Colleagues Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316399967 PECOS PAC ID: 8729011333 Enrollment ID: O20161006000618 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | 360 Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811637366 PECOS PAC ID: 5991184863 Enrollment ID: O20230322000939 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Entity Name | Ias Illinois Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265118723 PECOS PAC ID: 9638530991 Enrollment ID: O20230802002876 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Fatima I Ayuba-udoiwod, CRNA 1 Kish Hospital Dr, Dekalb, IL 60115-9602 Ph: (630) 936-4029 | Mrs Fatima I Ayuba-udoiwod, CRNA 1 Kish Hospital Dr, Dekalb, IL 60115-9602 Ph: (630) 936-4029 |
News Archive
Amgen will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC).
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The health care legislation under discussion in the Senate could allow states to remove some of the Affordable Care Act's consumer protections — including the prohibition that keeps insurers from limiting how much they'll pay for medically needy, expensive patients.
› Verified 5 days ago
Miss Krista Anne Weber, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Kish Hospital Dr, Dekalb, IL 60115 Phone: 630-936-4029 Fax: 630-936-4032 | |
Mrs. Marci Papiernik, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1 Kish Hospital Dr, Dekalb, IL 60115 Phone: 630-936-4029 Fax: 630-936-4032 | |
Janice Moore, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Kish Hospital Dr, Dekalb, IL 60115 Phone: 630-936-4029 | |
Alison Hunt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Kish Hospital Dr, Dekalb, IL 60115 Phone: 630-936-4029 | |
Sothida Berry, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Kish Hospital Dr, Dekalb, IL 60115 Phone: 815-936-4029 Fax: 815-936-4032 | |
Teresa Lacek, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Kish Hospital Dr, Dekalb, IL 60115 Phone: 815-756-1521 | |
Allison Smith, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Kish Hospital Dr, Dekalb, IL 60115 Phone: 815-756-1521 |